Clinical Trial Update: Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA) [NA]

View source ↗

Summary

This clinical trial update reports on imaging neuroendocrine tumors using PET with the radiotracer Fluoro-18-DOPA (F-DOPA); the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Snippet

Sponsor: Northwell Health | Conditions: Neuroendocrine Tumors | NA | Status: COMPLETED